[DOI] [PubMed] [Google Scholar] 13
Individuals with obesity have increased risk for heart disease, stroke, type 2 diabetes and kidney disease as well as several types of cancer
They increase glucose-dependent insulin secretion, suppress glucagon release, and slow gastric emptying by activating specific receptors in the gut and hypothalamus, thereby suppressing appetite and contributing to weight loss
A newer formulation (Egrifta WR) delivers 1.28mg daily with equivalent efficacy through improved bioavailability
3, the Danish drugmaker will present more extensive data from its two large Phase 3 trials of semaglutide, involving 3,808 total participants
It is an oral GLP-1, which means it can be taken orally rather than as an injection, Aroda explained